The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors.

Biomed Res Int · 2019 · PMC6348828 · PMID 30733963

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Our data demonstrated the efficacy of RDCI score in predicting 2-year retention rate and 1-year clinical response, with a statistical significance for EULAR good-moderate response and a clear trend for remission.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.